202 related articles for article (PubMed ID: 11289162)
41. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.
Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF
Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731
[TBL] [Abstract][Full Text] [Related]
42. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
43. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
44. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
[TBL] [Abstract][Full Text] [Related]
45. Expression and amplification of cyclin genes in human breast cancer.
Buckley MF; Sweeney KJ; Hamilton JA; Sini RL; Manning DL; Nicholson RI; deFazio A; Watts CK; Musgrove EA; Sutherland RL
Oncogene; 1993 Aug; 8(8):2127-33. PubMed ID: 8336939
[TBL] [Abstract][Full Text] [Related]
46. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.
Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J
Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081
[TBL] [Abstract][Full Text] [Related]
47. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer.
Yu J; Leung WK; Ebert MP; Leong RW; Tse PC; Chan MW; Bai AH; To KF; Malfertheiner P; Sung JJ
Br J Cancer; 2003 May; 88(10):1560-5. PubMed ID: 12771922
[TBL] [Abstract][Full Text] [Related]
48. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
49. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue.
Van Zee KJ; Calvano JE; Bisogna M
Oncogene; 1998 May; 16(21):2723-7. PubMed ID: 9652738
[TBL] [Abstract][Full Text] [Related]
50. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
Sakuma M; Akahira J; Ito K; Niikura H; Moriya T; Okamura K; Sasano H; Yaegashi N
Cancer Sci; 2007 Mar; 98(3):380-6. PubMed ID: 17270028
[TBL] [Abstract][Full Text] [Related]
51. Amplification of cyclin genes in colorectal carcinomas.
Leach FS; Elledge SJ; Sherr CJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(9):1986-9. PubMed ID: 8481900
[TBL] [Abstract][Full Text] [Related]
52. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.
Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V
Cancer Res; 2001 Nov; 61(21):8014-21. PubMed ID: 11691827
[TBL] [Abstract][Full Text] [Related]
53. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context.
Pau Ni IB; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Aina Emran N; Hisham Abdullah N; Syed Hussain SN
Pathol Res Pract; 2010 Apr; 206(4):223-8. PubMed ID: 20097481
[TBL] [Abstract][Full Text] [Related]
54. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.
Lee JS
Virchows Arch; 2007 Jun; 450(6):637-42. PubMed ID: 17479284
[TBL] [Abstract][Full Text] [Related]
55. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.
Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P
Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057
[TBL] [Abstract][Full Text] [Related]
56. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer.
Fackler MJ; McVeigh M; Mehrotra J; Blum MA; Lange J; Lapides A; Garrett E; Argani P; Sukumar S
Cancer Res; 2004 Jul; 64(13):4442-52. PubMed ID: 15231653
[TBL] [Abstract][Full Text] [Related]
57. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer.
Kang S; Kim B; Park SB; Jeong G; Kang HS; Liu R; Kim SJ
Int J Oncol; 2013 Nov; 43(5):1659-65. PubMed ID: 24026393
[TBL] [Abstract][Full Text] [Related]
58. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer.
Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB
Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719
[TBL] [Abstract][Full Text] [Related]
59. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
[TBL] [Abstract][Full Text] [Related]
60. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
